Clinical trials in multiple sclerosis: milestones

by Yinan Zhang, Amber Salter, Gary Cutter, Olaf Stüve
Published 2018-07-01

Evolution of clinical trials in multiple sclerosis

by Yinan Zhang, Amber Salter, Erik Wallström, Gary Cutter, Olaf Stüve
Published 2019-02-01

A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod

by Amber Salter, Samantha Lancia, Gary Cutter, Ruth Ann Marrie, Jason P. Mendoza, James B. Lewin, Robert J. Fox
Published 2021-06-01

Causes of death among commercially insured multiple sclerosis patients in the United States.

by Douglas S Goodin, Michael Corwin, David Kaufman, Howard Golub, Shoshana Reshef, Mark J Rametta, Volker Knappertz, Gary Cutter, Dirk Pleimes
Published 2014-01-01

Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1

by Nicole J. Ullrich, Jonathan M. Payne, Karin S. Walsh, Gary Cutter, Roger Packer, Kathryn North, Celiane Rey‐Casserly, the NF Clinical Trials Consortium
Published 2020-02-01

Clinical trials in multiple sclerosis: potential future trial designs

by Navid Manouchehri, Yinan Zhang, Amber Salter, Rehana Z. Hussain, Hans-Peter Hartung, Bernhard Hemmer, Ralf Linker, Benjamin M. Segal, Gary Cutter, Olaf Stüve
Published 2019-05-01

Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials

by Yinan Zhang, Natalia Gonzalez Caldito, Afsaneh Shirani, Amber Salter, Gary Cutter, William Culpepper, Mitchell Wallin, Peter Kosa, Bibiana Bielekova, Fred Lublin, Olaf Stuve
Published 2020-10-01

The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease

by Elizabeth L. Birchall, Harrison C. Walker, Gary Cutter, Stephanie Guthrie, Allen Joop, Raima A. Memon, Ray L. Watts, David G. Standaert, Amy W. Amara
Published 2017-05-01

Gender differences in quality of life among patients with myasthenia gravis in China

by Dong Dong, Marc Ka-chun Chong, Yushan Wu, Henry Kaminski, Gary Cutter, Xianhao Xu, Haifeng Li, Chongbo Zhao, Jian Yin, Siyue Yu, Jianfeng Zhu
Published 2020-09-01

Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients.

by Bianca Weinstock-Guttman, Robert Zivadinov, Gary Cutter, Miriam Tamaño-Blanco, Karen Marr, Darlene Badgett, Ellen Carl, Makki Elfadil, Cheryl Kennedy, Ralph H B Benedict, Murali Ramanathan
Published 2011-02-01

Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic e...

by Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, Jeremy Chataway, Nancy Chiaravalloti, Ulrik Dalgas, John DeLuca, Peter Feys, Massimo Filippi, Jennifer Freeman, Cecilia Meza, Matilde Inglese, Robert W. Motl, Maria Assunta Rocca, Brian M. Sandroff, Amber Salter, Gary Cutter, On behalf of the CogEx Research Team
Published 2020-05-01

A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple scler...

by Elliot M. Frohman, Gary Cutter, Gina Remington, Hongjiang Gao, Howard Rossman, Bianca Weinstock-Guttman, Jacqueline E. Durfee, Amy Conger, Ellen Carl, Katherine Treadaway, Eric Lindzen, Amber Salter, Teresa C. Frohman, Anjali Shah, Angela Bates, Jennifer L. Cox, Michael G. Dwyer, Olaf Stuve, Benjamin M. Greenberg, Michael K. Racke, Robert Zivadinov
Published 2010-01-01

Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1

by Jonathan M. Payne, Stephen J. C. Hearps, Karin S. Walsh, Iris Paltin, Belinda Barton, Nicole J. Ullrich, Kristina M. Haebich, David Coghill, Gerard A. Gioia, Alan Cantor, Gary Cutter, James H. Tonsgard, David Viskochil, Celiane Rey‐Casserly, Elizabeth K. Schorry, Joseph D. Ackerson, Laura Klesse, Michael J. Fisher, David H. Gutmann, Tena Rosser, Roger J. Packer, Bruce Korf, Maria T. Acosta, Kathryn N. North, the NF Clinical Trials Consortium
Published 2019-12-01